Laddar...
Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
BACKGROUND/PURPOSE: Spasticity is one of the most common symptoms in people with multiple sclerosis (MS). Conventional anti-spasticity agents have limitations in their efficacy and tolerability. Delta-9-tetrahydrocannabinol: cannabidiol (THC:CBD) spray, a cannabinoid-based medicine, is approved as a...
Sparad:
| I publikationen: | J Cent Nerv Syst Dis |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413425/ https://ncbi.nlm.nih.gov/pubmed/30886530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179573519831997 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|